XML 46 R32.htm IDEA: XBRL DOCUMENT
v3.25.1

Segment Information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Segment Reporting [Abstract] |
Schedule of Profit and Loss From Segments | For additional information on the year over year change of segment expenses refer to Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
|  | Year Ended December 31, |
|  | 2024 |  |  | 2023 |
|  | (in thousands) |
Research and development expenses: |  |  |  |  |  |
Personnel |  | $ | 39,239 |  |  | $ | 22,375 |
Clinical trials |  |  | 22,286 |  |  |  | 8,302 |
Development services |  |  | 16,417 |  |  |  | 12,486 |
Manufacturing of preclinical and clinical supplies |  |  | 15,523 |  |  |  | 8,498 |
License of intellectual property |  |  | 1,523 |  |  |  | 2,383 |
Other research and development costs (1) |  |  | 2,215 |  |  |  | 1,380 |
General and administration expenses |  |  | 27,938 |  |  |  | 19,236 |
Interest income |  |  | (10,025 | ) |  |  | (6,985 | )
Interest expense |  |  | 748 |  |  |  | — |
Net loss |  | $ | 115,864 |  |  | $ | 67,675 |
(1) Other research and development costs includes costs associated with information technology, travel, medical and scientific symposiums and conferences.

X
- Definition Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration